HeartBeam Inc. Q1 2025 Results and Business Update FAQ

What is the main topic of the press release?

The press release announces HeartBeam Inc.’s upcoming conference call to discuss Q1 2025 financial results and provide a business update, including regulatory progress and commercial-readiness efforts.

When will HeartBeam Inc. host the conference call?

The conference call is scheduled for May 13, 2025, at 4:30 p.m. Eastern Time.

Who will lead the conference call?

CEO Robert Eno and CFO Timothy Cruickshank will lead the conference call.

What updates will be provided during the call?

The call will include updates on regulatory progress, commercial-readiness efforts, and upcoming milestones.

Where can I find the press release and presentation?

The press release and presentation will be available on the company’s investor relations website. The full press release can also be viewed at https://ibn.fm/cogtu.

What is HeartBeam Inc. known for?

HeartBeam is a medical technology company focused on transforming cardiac care by developing the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions.

How many patents does HeartBeam Inc. hold?

The company holds 13 U.S. and 4 international-issued patents related to technology enablement.

Where can I get the latest news and updates about HeartBeam Inc.?

The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT.

What is the significance of HeartBeam’s technology?

HeartBeam’s technology is designed to deliver actionable heart intelligence outside of a medical facility, enabling physicians to identify cardiac health trends and acute conditions, thus redefining the future of cardiac health management.